OSMOZIS - BUY | EUR8.3 VS. EUR8 (+44%) Well placed to benefit from the energy and digital transition
OSMOZIS - BUY | EUR8.3 VS. EUR8 (+44%)Well placed to benefit from the energy and digital transition
Solid profitability in 2020-21
Transformation of the group under way
Further growth expected this year with EBITDA margin of 33% at least
Buy reiterated, on the back of a positive momentum
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.